Searchable abstracts of presentations at key conferences in endocrinology

ea0016p457 | Neuroendocrinology | ECE2008

Fatigue in breast cancer patients during chemotherapy: correlation with neuromuscular dysfunction and IGF-1 plasma levels

Baldelli Roberto , Pietrangeli Alberto , Cigliana Giovanni , Fabi Alessandra , Cognetti Francesco , Pugliese Patrizia , Appetecchia Marialuisa

Introduction: Adult growth hormone deficiency is associated with fatigue, tiredness and myalgias. The same clinical pattern can often be present in oncological patients during chemotherapy and follow up.Aim of the study: To conduct an extensive neuromuscular investigation of patients with breast cancer (BC), treated with taxol, in an attempt to explain their neuromuscular symptoms, eleven pre-menopausal patients with BC underwent a prospective protocol, ...

ea0081p395 | Environmental Endocrinology | ECE2022

The endocrine disruptor cadmium affects both ERα+ and ERα- breast cancer cell lines

Maria Bimonte Viviana , Sabato Claudia , Trocchianesi Sofia , Mersini Besharat Zein , Po Agnese , catanzaro giuseppina , Falcone Italia , Fabi Alessandra , Bei Roberto , Milella Michele , Vacca Alessandra , Ferretti Elisabetta , Migliaccio Silvia

The highly toxic heavy metal Cadmium (Cd) is widely spread in the environment and could exert estrogen-like activity in tissues including breast. Previous studies demonstrated that Cd binds to estrogen receptor α positive (ERα+) breast cancer (BC) cells. In this new study, we evaluated effects of Cd on both ERα+ and ERα negative (ERα-) BC models with the aim to further characterize the mechanisms involved in Cd-related BC carcinogenesis. Specifically, ...